Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.

Novo-Semide (March 05, 2010)

Starting date:
March 05, 2010
Posting date:
March 29, 2010
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-2010A108

Reason

Lots found to contain some out-of-weight specification tablets.

Depth of distribution

Wholesalers and pharmacies. No export

Affected products

Novo-Semide

DIN, NPN, DIN-HIM

DIN 00337730

Dosage form

Tablet

Strength

  • 20 mg

Lot or serial number

35307857A, 35307858A, 35307858B, 35307858C

Companies

Recalling Firm
Teva Canada Limited
30 Novopharm Court
Toronto Ontario
Canada M1B 2K9
Marketing Authorization Holder
Teva Canada Limited
30 Novopharm Court
Toronto Ontario
Canada M1B 2K9